TNXP 10-Q: SEC filing
Tonix Pharmaceuticals
Filed with the SEC on · accession 0001999371-26-024873
TNXP filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.
Summary of the filing
Tonix Pharmaceuticals filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and business updates.
Key details
✦ Ask GOAX AI about this filing — what it means for TNXP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TNXP?
Click hereFrequently asked questions
What did TNXP file with the SEC on Nov 9, 2026?
TNXP filed a 10-Q (SEC filing). Tonix Pharmaceuticals filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and business updates.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other TNXP SEC filings
- 8-K · SEC filingNov 9, 2026
- 8-K · SEC filingOct 15, 2026
- 8-K · Regulatory actionOct 2, 2026
- 8-K · Contract winSep 22, 2026
- 8-K · Ceo changeSep 8, 2026
- 8-K · Executive departureAug 18, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G · SEC filingAug 13, 2026
- 8-K · Guidance raiseAug 10, 2026
- 10-Q · SEC filingAug 10, 2026
Get alerts when TNXP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days